TP53 alterations and patterns of carcinogen exposure in a U.S. population-based study of bladder cancer
- PMID: 15906354
- DOI: 10.1002/ijc.21195
TP53 alterations and patterns of carcinogen exposure in a U.S. population-based study of bladder cancer
Abstract
The molecular pathology of bladder cancer has been the subject of considerable interest, and current efforts are targeted toward elucidating the interrelationships between individual somatic gene loss and both etiologic and prognostic factors. Mutation of the TP53 gene has been associated with more invasive bladder cancer, and evidence suggests that TP53 mutation, independent of stage, may be predictive of outcome in this disease. However, there is no consensus in the literature that bladder carcinogen exposure is associated with inactivation of the TP53 gene. Work to date has been primarily hospital based and, as such, subject to possible bias associated with selection of more advanced cases for study. We examined exposure relationships with both TP53 gene mutation and TP53 protein alterations in a population-based study of 330 bladder cancer cases in New Hampshire. Tobacco smoking was not associated with TP53 alterations. We found a higher prevalence of TP53 inactivation (i.e., mutation and nuclear accumulation) among hair dye users (odd ratio [OR] = 4.1; 95% confidence interval [CI] 1.2-14.7), and the majority of these mutations were transversions. Men who had "at risk" occupations were more likely to have mutated TP53 tumors (OR = 2.9; 95% CI 1.1-7.6). There also was a relative absence of TP53 mutation (OR = 0.4; 95% CI 0.0-2.9) and TP53 protein alterations (OR = 0.6; 95% CI 0.3-1.4) in bladder cancers from individuals with higher arsenic exposure. Our data suggest that there is exposure-specific heterogeneity in inactivation of the TP53 pathway in bladder cancers and that integration of the spectrum of pathway alterations in population-based approaches (capturing the full range of exposures to bladder carcinogens) may provide important insights into bladder tumorigenesis.
(c) 2005 Wiley-Liss, Inc.
Similar articles
-
Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens.Carcinogenesis. 2005 Jan;26(1):177-84. doi: 10.1093/carcin/bgh275. Epub 2004 Sep 3. Carcinogenesis. 2005. PMID: 15347601
-
Carcinogen exposure and gene promoter hypermethylation in bladder cancer.Carcinogenesis. 2006 Jan;27(1):112-6. doi: 10.1093/carcin/bgi172. Epub 2005 Jun 29. Carcinogenesis. 2006. PMID: 15987713
-
Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancer.Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb;3(1):19-24. Cancer Epidemiol Biomarkers Prev. 1994. PMID: 8118380
-
TP53 mutations in workers exposed to occupational carcinogens.Hum Mutat. 2003 Mar;21(3):240-51. doi: 10.1002/humu.10182. Hum Mutat. 2003. PMID: 12619109 Review.
-
TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.IARC Sci Publ. 2004;(157):247-70. IARC Sci Publ. 2004. PMID: 15055300 Review.
Cited by
-
Knockdown of ZNF280A inhibits cell proliferation and promotes cell apoptosis of bladder cancer.Histol Histopathol. 2024 Mar;39(3):367-379. doi: 10.14670/HH-18-640. Epub 2023 Jun 13. Histol Histopathol. 2024. PMID: 37345848
-
Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation.Front Immunol. 2023 Mar 17;14:955949. doi: 10.3389/fimmu.2023.955949. eCollection 2023. Front Immunol. 2023. PMID: 37006317 Free PMC article.
-
Nitrated Polycyclic Aromatic Hydrocarbon (Nitro-PAH) Signatures and Somatic Mutations in Diesel Exhaust-Exposed Bladder Tumors.Cancer Epidemiol Biomarkers Prev. 2023 Jun 1;32(6):840-847. doi: 10.1158/1055-9965.EPI-22-1208. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 36996403 Free PMC article.
-
Arsenic Speciation and Metallomics Profiling of Human Toenails as a Biomarker to Assess Prostate Cancer Cases: Atlantic PATH Cohort Study.Front Public Health. 2022 Jul 7;10:818069. doi: 10.3389/fpubh.2022.818069. eCollection 2022. Front Public Health. 2022. PMID: 35875010 Free PMC article.
-
Arsenic and Human Health: Genotoxicity, Epigenomic Effects, and Cancer Signaling.Biol Trace Elem Res. 2022 Mar;200(3):988-1001. doi: 10.1007/s12011-021-02719-w. Epub 2021 Apr 16. Biol Trace Elem Res. 2022. PMID: 33864199 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous